INTRODUCTION 49
The polysaccharide capsule is a major virulence factor of the human pathogen 50
Streptococcus pneumoniae (pneumococcus) and more than 90 different capsular types are 51 known today, which differ in the chemical structure of their capsular polysaccharides (1). 52
These differences are reflected in the type-specific reaction with anticapsular antibodies, by 53 which a serotype is determined and cross-reactive serotypes are pooled into serogroups. 54
The serogroup 19 contains, among others, serotypes 19F and 19A, which belong to the 55 clinically most relevant serotypes (2). Based on both genetic background and chemical 56 analyses the serotype 19A and 19F oligosaccharide repeating unit structures have been 57 determined to be trisaccharides of glucose (Glc), rhamnose (Rha) and N-acetyl-58 mannosamine (ManNAc), differing only in the glycosidic linkage between glucose and 59 rhamnose: 60
19F: →2)-α-L-Rha-(1→PO 4 →4)-β-D-ManNAc-(1→4)-α-D-Glc-(1→ 61

19A: →3)-α-L-Rha-(1→PO 4 →4)-β-D-ManNAc-(1→4)-α-D-Glc-(1→ (1, 3-5). 62
Based on chemical analyses two types of 19A oligosaccharide structures have been 63 described (6, 7). In addition to the genetically proposed structure above, an alternative with a 64 serotype 19F backbone and two side chains of β-D-GlcNAc-(1→3)-β-D-Gal-(1→P→2) and 65 α-L-Fuc-(1→P→3) has been reported based on chemical analysis (7). The polysaccharide 66 structures appear to vary with different in vitro growth conditions (6). Influence of the 67 nutritional environment on the pneumococcal polysaccharide capsule could have biological 68 consequences, as this would potentially impair any intervention or test targeting the 69 pneumococcal capsule. For example, the fungus Cryptococcus neoformans is known to be 70 able to change the capsule structure in vitro and also during infection (8-11), and those 71 changes have been shown to lead to altered antigenicity (8, 11) . 72
Because polysaccharides for pneumococcal vaccine production are derived from in vitro 73 cultures, a nutrient-dependent variation could lead to antigenic preparations which differ from 74 the in vivo antigen. 75 on September 7, 2016 by Universitaetsbibliothek Bern http://iai.asm.org/ Downloaded from 6 Strains were further characterized with plyNCR-RFLP as previously described (21, 22 human saliva from ten healthy volunteers was collected using Salivette (Sarstedt, 158
Nümbrecht, Germany). After centrifugation with 1500 x g for 2 minutes samples were pooled 159 and sterile filtrated with 0.22μm centrifugal filter units (Millipore, Billerica, MA) at 5000 x G for 160 20 minutes as previously described (30) . 161
Capsules of strains grown in different growth media were released by overnight incubation in 162 1% phenol, separated from the bacteria by centrifugation and filtration, and then purified with 163 sodium acetate/ethanol precipitation, followed by protease and nuclease digestion of 164 remaining contaminants, and finally cut-off filtrated as described (25). The extracted 165 polysaccharides were then completely hydrolyzed by trifluoroacetic acid (TFA) (31). The 166 monosaccharide composition of capsular polysaccharides of strains grown in CDM was 167 determined by high performance liquid chromatography (HPLC) analysis of fluorescently 168 labelled monosaccharides as previously described (25, (32) (33) (34) (35) , whereas the PIM extracts 169 were analyzed on a system consisting of an ASI-100 autosampler and P680 HPLC pump 170 (DIONEX, Sunnyvale, CA, USA) with an injection volume of 20 µL per sample. Separation of 171 the monosaccharide was done with a flow rate of 0.85 mL/min as follows: 6% solvent B 172 isocratic for 35 minutes followed by a linear gradient from 6 to 12% solvent B over 20 173 minutes. Then, the column was washed with 100% solvent B for 10 minutes and 100% 174 solvent A for 15 minutes followed before re-equilibrating the system with 6% solvent B for 10 175 minutes. Total run time was 90 minutes and data was collected for 55 minutes using an L-176 7480 Fluorescence Detector (Merck Hitachi, Darmstadt, Germany). A Luna 5 mm, C18 177 on September 7, 2016 by Universitaetsbibliothek Bern http://iai.asm.org/ Downloaded from 8 column (Phenomenex, Torrance, CA) was used for separation and column temperature was 178 maintained at 24 °C using a TCC-100 column oven (Thermo Scientific Dionex, Reinach, 179 Switzerland). Peaks were identified by comparing retention time with monosaccharide 180 standards analyzed in the same run ( Figure S1A ). As N-acetylated aminosugars are 181 deacetylated during hydrolysis with TFA (36), deacetylated aminosugars were used as 182 standards for their acetylated counterpart (e.g., mannosamine for N-acetyl-mannosamine). 183
Negative controls included in each experiment were medium negative control for growth, 184 extraction, hydrolysis and HPLC. HPLC raw data was exported into GraphPad Prism 185 (Version 5, GraphPad Software, Inc.) for creating figures. 186
Gas chromatography -mass spectrometry (GC-MS). GC-MS analysis of alditol acetates 187
of the polysaccharide hydrolysates from strains 109.44 grown in PIM and 501.24 grown in 188 PIM, pooled saliva, and CDM glucose was performed as a control, as previously described 189 (37, 38). 190
Nuclear magnetic resonance spectroscopy (NMR). NMR data were collected on a Bruker 191
Avance II (500 MHz; resonance was suppressed using a classical presaturation scheme. HSQC spectra were 196 collected on a Bruker Avance III HD (600 MHz) spectrometer equipped with an inverse 5mm 197 TCI helium cryoprobe. All spectra were acquired at a regulated temperature of 298 K and 198 calibrated to the residual water peak (4.766 ppm). For the interpretation of the received 199 carbon and hydrogen shifts, results from previous studies were used as guidance for the 200 capsule structure determination of the 19A capsule extracts (4, 39, 40) . tract between 1998 and 2011 were analyzed. In total, 158 19A isolates were screened for 211 the three described subtypes using a two-step PCR protocol described above. Figure 1A ). There was still a significant 217 shift even after data from the PCV7 introduction year (2006) were excluded (p=0.03). We 218 found no evidence for a difference of 19A subtypes distribution according to age (Pre versus 219 post introduction of PC7 eras over age groups of ≤1, 2-4, 5-15 and >15 years; Fisher's exact 220 test; p= 0.3). In addition, there was no indication of a time trend for the frequency of 19A 221 subtypes before the PCV7 was present (Data not shown). As for molecular types derived by 222 plyNCR-RFLP typing, plyNCR-RLPF types 1 (55.7%) and 16 (18.4%) were the most 223 frequent within the 158 strains but we did not detect a significant shift of molecular types 224 between pre and post PCV7 introduction era ( Figure 1B ). In addition we revealed that 225 antibiotic resistances within the 19A strains were generally high and that 19A II is 226 significantly more susceptible towards penicillin, erythromycin, and SXT as compared to the 227 other subtypes ( Figure 1C) . However, calculating a multivariate logistic regression model we 228 confirmed that there was strong evidence that, compared to 19A I, the odds of observing 229 subtype 19A II after introduction of PCV7 was 6 times higher than before PCV7, and that this 230 on September 7, 2016 by Universitaetsbibliothek Bern http://iai.asm.org/ Downloaded from association was independent of antimicrobial resistance, geographical region, age or sex 231 (p = 0.005; Table S1 ). 232
We then selected at least one strain of each subtype for further laboratory analysis to 233 determine capsular composition of the different subtypes (Table 1) Figure S1B ). 240
No rhamnose peaks were detected for the strain without a capsule, but small amounts of 241 glucose and higher amounts of amino sugars including mannosamine could be detected, 242 most likely deriving from cell wall polysaccharide (CWPS) and from murein layer. 243
Furthermore, hydrolysis with TFA is known to produce varying amounts of hydrolysis-derived 244 (di)saccharides ( Figure S1B ). This contamination was usually present in capsule extracts 245 from tested strains and was higher in amount as compared to the commercially available 246 purified pneumococcal polysaccharide (Figure 2) (Figure 2A) . We 259 then analyzed the capsular extracts from the ATCC standard ( Figure 2B ) and from 19A 260 subtypes grown in the undefined medium PIM ( Figure 2C ). Again, no additional neutral 261 monosaccharides were detected and thus reported additional monosaccharides (galactose 262 and fucose would have been expected on the neutral side based on the literature (6)) were 263 not seen in our preparations. As HPLC allows only the identification of peaks based on their 264 retention time in comparison to standards, the presence of the neutral monosaccharides in 265 capsule extracts was confirmed for 109.44 (19A-I) grown in CDM with 55 mM Glucose 266 ( Figure S3A ) and PIM ( Figure S3B ) and 501.24 (19A-II) grown in PIM ( Figure S3C ) with GC-267
MS (which revealed glucose and rhamnose in all preparations). GC-MS also confirmed a 268
lower degree of contamination with cell wall and other compounds in the ATCC standard 269 compared to subtype capsule extracts ( Figure S3D) . 270
To mimic saccharide nutrients present in the natural human environment of S. pneumoniae, 271
109.44 (19A-I) was grown in CDM with monosaccharides contained in human mucin (5.5 272 mM total concentration of the mucin building monosaccharides in ratios as determined for 273 the salivary mucin MG1) and 501.24 (19A-II) was also grown in pooled human saliva 274 collected from 10 healthy volunteers after sterile filtration. No additional neutral 275 monosaccharides were identified to be present in the polysaccharide capsule extracted from 276 the strains grown under these conditions compared to capsule extracted from strains grown 277 in CDM supplemented with glucose or PIM but the signal to noise ratio was much lower in 278 saliva grown capsule ( Figure S2 and S3E) . 279
NMR analyses reveal no structural difference between subtypes. 280
In order to confirm the proposed structures of the oligosaccharides we compared the 281 anomeric region (4.8-6.0 ppm) in the The spectra were again consistent within 19A subtypes but different from serotype 19F 290 capsular polysaccharide ( Figure 3A) . Based on those results, it can be stated that the 291
capsule composition is independent of tested growth medium as the patterns were identical 292 to each other and to the ATCC reference 19A polysaccharide. Only a slight shift was 293 observed for the capsule analysis of the Hungary 19A-6 strain. However, the overlay of the 294
C HSQC-NMR spectra of this isolate grown in PIM and CDM supplemented with 295 glucose revealed identical patterns for the H-atoms of the anomeric region as illustrated for 296 rhamnose, N-acetyl mannosamine and glucose ( Figure 3B ). The full 2D Spectrum is shown 297 in Figure S4 . In this study we demonstrated that the distribution of pneumococcal serotype 19A subtypes 301 changed after the implementation of PCV7 in Switzerland. However, all analyzed capsular 302 extracts from serotype 19A subtypes grown in defined medium CDM and the undefined 303 medium PIM showed a capsule composition which was consistent with the one proposed 304 based on genetic analysis. Furthermore, we did not find any evidence for additional side 305 chains altered repeat units or linkage changes under different nutritional conditions. . Given the identical capsule structure for all tested 19A subtypes as revealed for the first time 314 in our study using NMR, HPLC and GC-MS, no alteration of vaccine effectiveness due to 315 capsular differences between individual subtypes is suggested. Furthermore, the lack of anti-316 19F antibody cross-protection against serotype 19A can therefore not be explained by 317 selection of 19A subtypes with altered capsule structures which supports recent discoveries 318 suggesting a general low protection due to conformational difference in polysaccharide 319 structures of 19F and 19A (17, 18 vaccine selection pressure after the introduction of PCV13 would be unexpected, although it 332 has been speculated that there might be a difference in capsule thickness for different 333 subtypes which might lead to differences in opsonophagocytotic susceptibility (19) . 334
Previously reported experiments showing additional side chains in 19A isolates grown in PIM 335
could not be replicated (6). An explanation for this finding might be a strain-specific genetic 336 alteration in previous studies. Indeed, it has been recently reported that serotype 11D has 337 two different capsular polysaccharide repeating units in a ratio of 1:3 (25% and 75%, 338 respectively) due to a bispecific transferase WcrL (42). Although precursors of capsular 339 galactose and N-acetyl-glucosamine might be available due to their synthesis in other 340 pathways (43), the (environment-dependent) addition of 2 side chains comprised of three 341 additional monosaccharides is expected to be reflected with at least additional 342 glycosyltransferase enzymes within the capsule locus involved in their linkage, and a switch 343 of the glycosidic linkage between rhamnose and glucose would suggest mutations resulting 344 in bispecificity or two copies of the wzy polymerase (3). To our knowledge, neither of these 345 two possibilities have been detected in 19A strains (3). However, variation of the repeat unit 346 structure would be suspected to have an influence on the antigenicity thus resulting in 347 suspect serotyping results (i.e., less reactive with anti-19A antiserum) which were not 348 observed in this study. However, given the increasing vaccine selection pressure after the 349 introduction of PCV13, we recommend capsule structure determination of emerging clones 350 and/or serotypes given recent discoveries of novel serotypes and capsule variants (42, 44-351 47 it has been reported that disaccharides can be formed during hydrolysis based on different 364 stability of intramolecular bonds (32) which also occurred in our experiments. 365
Results showed traces of contamination of cell-wall components in our preparations, which 366 is a common co-extracted compound in pneumococcal capsule preparations probably 367 because the capsule is covalently linked to the cell wall (32, 49, 50) . To determine linkage 368 analysis and further characterization of the capsule oligosaccharide repeat units, we 369 performed additional 1D and 2D NMR analysis of polysaccharides from unhydrolyzed 370 capsule extracts. The major limitation of this study is that the number of different 19A 371 subtype strains analyzed was rather small. However, we chose at least one sample of each 372 of the currently known subtypes and it can therefore be expected that our study is 373 representative. Although we did not find evidence for nutrition-dependent variations of 374 capsule structures, this cannot be considered as final proof for an absence of such 375 variations. Furthermore, we did not have the same strains or capsule extracts for which a 376 nutrient-dependent variation has been reported as a reference for the assays used (6). 377
In summary, the polysaccharide capsule composition for tested serotype 19A subtypes was 378 consistently composed of the same trisaccharide repeat unit. 
